Optimal Treatment Timing Could Boost Cancer Therapy EfficacyDecember 10, 2025 at 09:05 AM EST
Administering chemotherapy at specific times could significantly improve outcomes for brain cancer patients. Washington University in St. Louis researchers discovered that treatment timing plays a crucial role in how effectively glioblastoma patients respond to standard drug protocols. Funding came from NCI, Siteman Cancer Center, and National Institutes of Health, with the cancer center operating at WashU Medicine and Barnes-Jewish Hospital. As more teams at firms like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) undertake R&D programs aimed at developing novel therapies against… NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP About TinyGems TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge. To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only) For more information, please visit https://www.TinyGems.com Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer TinyGems TinyGems is powered by IBN More NewsView More
Why Taiwan Semiconductor's 6.5% Dip Could Be a Smart Buy ↗
Today 18:39 EST
Via MarketBeat
RTX Surges to Record Highs as Defense Orders Explode ↗
Today 17:42 EST
Via MarketBeat
Tickers
RTX
Smart Money Is Buying Auto Suppliers, Not Car Brands ↗
Today 16:49 EST
Higher Beef Prices Are Here: Best Steakhouse Stocks for 2026 ↗
Today 15:07 EST
Via MarketBeat
AI Runs on Power—And Constellation Energy Controls the Switch ↗
Today 14:16 EST
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|